BeStock  

Quest Diagnostics DGX

$258.28 −$0.81 (-0.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $259.00 +0.28%
Open$262.00
Prev close$259.09
Day range$257.56 – $262.96
Volume1.37M
Market cap$28.42B
P/E (TTM)25.7
Dividend yield1.31%

DGX Stock News

Headlines matching Quest Diagnostics or the DGX ticker, most recent first.

  • UBS Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $245 PositiveMarket news · 8 Sep 2026 · Direct mention
  • Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $250Market news · 23 Sep 2026 · Direct mention
  • Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $260Market news · 22 Sep 2026 · Direct mention
  • Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $260 PositiveMarket news · 21 Sep 2026 · Direct mention
  • Quest Diagnostics(DGX.US) Officer Sells US$5.51 Million in Common StockMarket news · 1 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market news · 19 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $260Market news · 29 Jul 2026 · Direct mention
  • Truist Financial Maintains Quest Diagnostics(DGX.US) With Hold Rating, Maintains Target Price $250Market news · 29 Jul 2026 · Direct mention
  • Argus Research Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $260 PositiveMarket news · 29 Jul 2026 · Direct mention
  • J.P. Morgan Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $250 PositiveMarket news · 28 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $265Market news · 25 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Quest Diagnostics(DGX.US), With a Forecast Between $232 to $260Market news · 24 Jul 2026 · Direct mention
  • Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $230Market news · 16 Jul 2026 · Direct mention
  • BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $245 PositiveMarket news · 13 Jul 2026 · Direct mention
  • Baird Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $236 PositiveMarket news · 13 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on DGX.

Sign in to join the discussion.

Scroll to Top